MARKET

BIO

BIO

Bio Rad Labs Inc
NYSE
238.68
-2.34
-0.97%
After Hours: 238.68 0 0.00% 16:20 05/09 EDT
OPEN
240.94
PREV CLOSE
241.02
HIGH
243.15
LOW
238.09
VOLUME
244.72K
TURNOVER
--
52 WEEK HIGH
386.54
52 WEEK LOW
215.38
MARKET CAP
6.69B
P/E (TTM)
-3.1323
1D
5D
1M
3M
1Y
5Y
1D
Bio-Rad: With Low Debt And A Stock Price Drop, Is The Company Undervalued?
Seeking Alpha · 1d ago
Artisan Mid Cap Value Fund Q1 2025 Commentary
Seeking Alpha · 5d ago
Analysts Predict 16% Gains Ahead For The Holdings of PBUS
NASDAQ · 5d ago
Weekly Report: what happened at BIO last week (0428-0502)?
Weekly Report · 5d ago
Bio-Rad Laboratories First Quarter 2025 Earnings: EPS: US$2.29 (vs US$13.46 in 1Q 2024)
Simply Wall St · 05/03 12:33
Bio-Rad Laboratories Balances Growth and Challenges in Q1 2025 Earnings Call
TipRanks · 05/03 00:13
Bio-Rad Laboratories Is Maintained at Buy by UBS
Dow Jones · 05/02 22:56
Bio-Rad Laboratories Price Target Cut to $310.00/Share From $355.00 by UBS
Dow Jones · 05/02 22:56
More
About BIO
More
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Recently
Symbol
Price
%Change
    BIO
  • 238.68
  • -0.97%

Webull offers Bio Rad Laboratories Inc stock information, including NYSE: BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.